Gene: DROSHA
Official Full Name: drosha ribonuclease IIIprovided by HGNC
Gene Summary: This gene encodes a ribonuclease (RNase) III double-stranded RNA-specific ribonuclease and subunit of the microprocessor protein complex, which catalyzes the initial processing step of microRNA (miRNA) synthesis. The encoded protein cleaves the stem loop structure from the primary microRNA (pri-miRNA) in the nucleus, yielding the precursor miRNA (pre-miRNA), which is then exported to the cytoplasm for further processing. In a human cell line lacking a functional copy of this gene, canonical miRNA synthesis is reduced. Somatic mutations in this gene have been observed in human patients with kidney cancer. [provided by RefSeq, Sep 2016]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO01708 | DROSHA Knockout cell line (HeLa) | Human | DROSHA | 1:3~1:6 | Negative | Online Inquiry |
KO01709 | DROSHA Knockout cell line (HCT 116) | Human | DROSHA | 1:2~1:4 | Negative | Online Inquiry |
KO01710 | DROSHA Knockout cell line (HEK293) | Human | DROSHA | 1:3~1:6 | Negative | Online Inquiry |
KO01711 | DROSHA Knockout cell line (A549) | Human | DROSHA | 1:3~1:4 | Negative | Online Inquiry |
DROSHA Gene Knockout Cell Lines are genetically modified cell lines in which the DROSHA gene, crucial for the processing of microRNAs, has been selectively disrupted. This targeted knockout approach is instrumental for studying gene regulation, RNA processing, and the intricate networks involved in cellular responses to various stimuli. In particular, DROSHA plays a critical role in the initial step of microRNA biogenesis, which influences gene expression by regulating the degradation of messenger RNA and modulating pathways involved in cell proliferation, differentiation, and apoptosis.
The DROSHA Gene Knockout Cell Lines function by utilizing CRISPR/Cas9 technology to create precise alterations in the DROSHA gene, leading to a complete loss of its expression. This allows for a clear examination of the cellular impacts and downstream effects resulting from the absence of this pivotal enzyme. In research and clinical settings, these cell lines are invaluable for deciphering the roles of microRNAs in various diseases, including cancers and neurodegenerative disorders, as well as advancing our understanding of RNA biology.
One of the key advantages of DROSHA Gene Knockout Cell Lines is their specificity and reliability compared to traditional siRNA approaches, which often exhibit off-target effects and transient effects. These cell lines provide a stable genetic context, enabling long-term studies and experimental reproducibility. Additionally, the ease of manipulating these cell lines fosters the exploration of therapeutic interventions targeting microRNA pathways, thus facilitating translational research that can lead to novel treatment strategies.
For researchers, clinicians, and pharmaceutical companies, the DROSHA Gene Knockout Cell Lines represent a critical tool for advancing our understanding of gene regulation and developing targeted therapies. Our company's expertise in genetic engineering and commitment to high-quality biological products ensures that these cell lines are rigorously validated, providing researchers with the confidence and support necessary to drive their innovative studies forward.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.